CMS Proposes To Deny Most HCPCS Code Requests For DMEPOS Items
This article was originally published in The Gray Sheet
Executive Summary
CMS met this week, and will again on June 3, to hear arguments in support of establishing new or revised level II HCPCS codes for 33 different durable medical equipment, prosthetics and orthotics items and medical supplies. But in preliminary rulings the agency signaled plans to deny all but two of the requests.
You may also be interested in...
Eye Disorders Are Focus Of Novel Neurostimulation Technologies
Neurostimulation technology is migrating into the ophthalmology field, and the implications could be significant for the millions of patients worldwide with degenerative eye diseases, including retinitis pigmentosa and age-related macular degeneration, as well as those with moderate-to-severe dry eye disease. Companies active in this space include Second Sight Medical Products, Retina Implant AG, Pixium Vision, Nano Retina, and many others.
Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding
Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.
Frustrated Manufacturers Will Go To HCPCS Meetings With Few Expectations
Medical equipment manufacturers are pushing CMS to establish a more open and responsive process for assigning new reimbursement claims codes following what they consider to be fresh round of unwarranted coding denials for 2008